Dennis M. Lanfear, President and CEO at Coherus BioSciences, Inc. (CHRS), sold 400 shares at $31.75 ($13K) on 2015-11-30, disclosed to the SEC on 2015-12-02.
Scheduled sale ($13k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CHRS | SELL | 2019-11-25 | $464K | — | Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |